ADARx Pharmaceuticals raised $446 million in a biotech IPO backed by AbbVie

发生了什么

The San Diego RNA drug developer sold 26.3 million shares at $17 apiece, with AbbVie investing up to $100 million in a concurrent private placement

摘要按规则整理自下方来源原文

来源